Close

CluePoints Supports Launch of RBQM Live 2023 as Premier Event Sponsor

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

LOTTE BIOLOGICS Enters Contract Manufacturing Collaboration

LOTTE BIOLOGICS, on September 1, 2025, announced that it...

Cook Medical Says Extra Tariff to Be Passed to US Customers

According to medical device firm Cook Medical, the costs...

FDA Aims to Decrease Animal Testing as Tech Gathers Pace

Drug developers are raising the adoption of AI technologies...

$2 Billion Expansion By J&J in North Carolina Facility

Johnson & Johnson on August 21, 2025, went on...

CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management (RBQM) Software for clinical trials, has launched registration for RBQM Live 2023, the foremost virtual event known for shaping the future of RBQM.

This year, the free-to-attend event, which takes place from September 6-7 including a workshop on Risk-Based Data Management on September 8, is a must-attend for anyone working with, or planning to adopt, Risk-Based Quality Management (RBQM) and risk-based approaches in general within clinical trials. Sponsored by CluePoints, all sessions are free, but registration is essential as places are limited.

RBQM Live provides a unique opportunity to discuss the current RBQM landscape, look ahead to the future, and share practical experiences. There is something for everyone, no matter the size or type of organization or the delegate’s experience.

Day 1 on September 6, 2023, will focus on how RBQM has recently transformed. The keynote address, The Global Transformation of RBQM – Research Study Findings from a 2023 Survey and Executive Roundtable Discussions, will be given by Ken Getz, Executive Director and Professor, Tufts Center for the Study of Drug Development.

Other highlights include technology showcases, a briefing on ICH E6 (R3) & E8 guidance updates, and a masterclass on understanding RBQM during the design and planning process.

Day 2, on September 7, 2023, focuses on technology with a keynote panel discussion titled ‘The RBQM Journey: Understanding RBQM Technology Evolution and How to Navigate the Future.’

Other highlights include a panel discussion on the evolution of adaptive QTLs and a masterclass on understanding the RBQM process and documentation phase.

On September 8, 2023, the event will also offer a ‘Risk-Based Data Management Revolution’ workshop.

Patrick Hughes, Co-Founder and Chief Commercial Officer of CluePoints, commented, “Risk-Based Quality Management is continuing to grow and transform the clinical trials space. We are delighted to be once again bringing together industry leaders to share their expertise and experience at RBQM Live. These sessions are designed to help you and your team succeed with RBQM – whether you are considering adopting it for the first time or looking to build on your existing approaches. There is something in it for everyone as we all contribute to this paradigm shift in adopting RBQM.”

RBQM Live 2023 takes place from September 6 to September 7, including the workshop on the 8th. For more information and to register for your free spot, visit rbqmlive.com. The full speaker line-up will be announced in early June.

 

Latest stories

Related stories

LOTTE BIOLOGICS Enters Contract Manufacturing Collaboration

LOTTE BIOLOGICS, on September 1, 2025, announced that it...

Cook Medical Says Extra Tariff to Be Passed to US Customers

According to medical device firm Cook Medical, the costs...

FDA Aims to Decrease Animal Testing as Tech Gathers Pace

Drug developers are raising the adoption of AI technologies...

$2 Billion Expansion By J&J in North Carolina Facility

Johnson & Johnson on August 21, 2025, went on...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back